secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001493152-24-018036
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed subsidiary Lucid Diagnostics raises $11.6M in Series B-1 preferred stock offering
--------------------------------------------------------------------------------

- Lucid Diagnostics, PAVmed's majority-owned subsidiary, raised ~$11.6M via Series B-1 Convertible Preferred Stock.
- Sold approx 11,634 shares at $1,000/share to accredited investors; closed May 6, 2024.
- Lucid filed Certificate of Designation for Series B-1 Preferred and entered Registration Rights Agreement.
- Details are incorporated by reference from Lucid Diagnostics' separate 8-K filed May 7, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224018036/0001493152-24-018036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224018036/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-018036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer